Desmopressin and the risk of hyponatremia: A population-based cohort study

BACKGROUND: Desmopressin was approved by the Food and Drug Administration (FDA) in 1978 for use in diabetes insipidus and bleeding disorders, but it is also prescribed off-label for patients with nocturia. Quantifying the potential risks facing adult patients taking desmopressin has taken on added i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fralick, Michael, Schneeweiss, Sebastian, Wallis, Christopher J. D., Jung, Emily H., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802819/
https://www.ncbi.nlm.nih.gov/pubmed/31634354
http://dx.doi.org/10.1371/journal.pmed.1002930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802819/
https://www.ncbi.nlm.nih.gov/pubmed/31634354
http://dx.doi.org/10.1371/journal.pmed.1002930

Ejemplares similares